ZTS — Zoetis Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Zoetis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,675	7,776	8,080	8,544	9,256
Cost of Revenue
Gross Profit	4,630	5,483	5,630	6,020	6,542
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4,679	5,288	5,424	5,608	6,123
Operating Profit	1,996	2,488	2,656	2,936	3,133
Net Income Before Taxes	1,996	2,488	2,656	2,936	3,133
Provision for Income Taxes
Net Income After Taxes	1,636	2,034	2,111	2,340	2,496
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,638	2,037	2,114	2,344	2,486
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,638	2,037	2,114	2,344	2,486
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.49	4.39	4.57	5.16	5.55
Dividends per Share